Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (SHA:688336)
China flag China · Delayed Price · Currency is CNY
60.42
+1.67 (2.84%)
At close: Feb 6, 2026

SHA:688336 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
246.11459.49933.261,0911,6141,778
Short-Term Investments
444.54863.59344.19--50
Trading Asset Securities
1,033910.54603.871,486752.05932.63
Cash & Short-Term Investments
1,7242,2341,8812,5772,3662,761
Cash Growth
30.78%18.73%-27.00%8.93%-14.31%141.69%
Accounts Receivable
369.36147.14133.24149.35256.97102.92
Other Receivables
0.350.030.20.290.530.5
Receivables
369.7147.17133.44149.65257.5103.42
Inventory
243.56229.6194.96227210.14225.08
Other Current Assets
3,52349.6440.0932.5438.0932.3
Total Current Assets
5,8602,6602,2502,9862,8723,122
Property, Plant & Equipment
1,5251,5391,5621,4261,3711,287
Long-Term Investments
31.551,1401,020109.4122.37105.59
Goodwill
0.640.640.640.640.640.64
Other Intangible Assets
212.83223.96240.16195.73196.55221.17
Long-Term Deferred Tax Assets
105.78129.62145.74173.43155.31103.18
Long-Term Deferred Charges
296.27228.5444.44114.0297.6779.48
Other Long-Term Assets
779.4943.6842.1692.7673.5935.53
Total Assets
8,8115,9655,3055,0984,8894,954
Accounts Payable
46.1434.9621.9315.9116.2721.36
Accrued Expenses
45.77174.93181.256.18127.71177.5
Short-Term Debt
-50.0250.03150.1--
Current Income Taxes Payable
7.181.31.31.20.210.21
Current Unearned Revenue
2,60620.216.7719.553.2515.42
Other Current Liabilities
147.1335.4936.91132.1568.0165.83
Total Current Liabilities
2,852316.91308.14375.09215.45280.32
Long-Term Unearned Revenue
99.86111.24118.33123.79134.28153.11
Total Liabilities
2,952428.15426.47498.88349.73433.44
Common Stock
616.79616.79616.79616.79616.21616.21
Additional Paid-In Capital
2,3292,3102,3032,3092,3012,273
Retained Earnings
2,9622,6391,9851,6911,6411,623
Comprehensive Income & Other
-8.42.44-8.71-10.67-17.33-9.68
Total Common Equity
5,8995,5684,8964,6064,5424,503
Minority Interest
-39.92-30.76-17.58-6.32-2.4617.29
Shareholders' Equity
5,8595,5374,8794,6004,5394,520
Total Liabilities & Equity
8,8115,9655,3055,0984,8894,954
Total Debt
-50.0250.03150.1--
Net Cash (Debt)
1,7242,1841,8312,4272,3662,761
Net Cash Growth
35.94%19.24%-24.55%2.59%-14.31%141.69%
Net Cash Per Share
2.763.532.983.943.934.70
Filing Date Shares Outstanding
616.79616.79616.79616.79616.21616.21
Total Common Shares Outstanding
616.79616.79616.79616.79616.21616.21
Working Capital
3,0082,3431,9422,6112,6562,841
Book Value Per Share
9.569.037.947.477.377.31
Tangible Book Value
5,6855,3434,6554,4094,3444,281
Tangible Book Value Per Share
9.228.667.557.157.056.95
Buildings
-626.77626.77531.48531.48516.17
Machinery
-1,2201,1961,0431,0351,007
Construction In Progress
-749.65687.81717.11572.47434.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.